Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | JAK2 | O60674 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.53 |
| ▸ | CES2 | O00748 | 2/20 | 0.51 |
| ▸ | CES1 | P23141 | 2/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 3/20 | 0.47 |
| ▸ | HTT | P42858 | 3/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | LTB4R2 | Q9NPC1 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL836988 | 0.93 | TP53 (0.51) | NPC1JAK2RAB9APAX8CES2 | |
| SCHEMBL28046943 | 0.87 | FFAR4 (0.50) | NPC1JAK2RAB9APAX8CES2 | |
| SCHEMBL27829156 | 0.85 | TP53 (0.65) | NPC1JAK2RAB9APAX8CES2 | |
| SCHEMBL28533625 | 0.84 | NPC1 (0.54) | NPC1JAK2RAB9APAX8CES2 | |
| SCHEMBL7643097 | 0.84 | NPC1 (0.54) | NPC1JAK2RAB9APAX8CES2 | |
| SCHEMBL12472589 | 0.84 | NPC1 (0.54) | NPC1JAK2RAB9APAX8CES2 | |
| SCHEMBL18240156 | 0.84 | NPC1 (0.54) | NPC1JAK2RAB9APAX8CES2 | |
| SCHEMBL18240146 | 0.84 | NPC1 (0.54) | NPC1JAK2RAB9APAX8CES2 | |
| SCHEMBL155509 | 0.84 | ALOX5 (0.44) | NPC1RAB9ATP53ALDH1A1LMNA | |
| SCHEMBL4130517 | 0.83 | NPC1 (0.53) | NPC1JAK2RAB9APAX8CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1206921-C | Antimicrobial composition comprising an oxidoreductase and an enhancing agent of the N-hydroxy anilide-type | NOVO JYMEZ AS (DK) | 2005-06-22 | — | — | CN | claimed |
| CN-1325270-A | Antimicrobial composition comprising an oxidoreductase and an enhancing agent of the N-hydroxy anilide-type | NOVO JYMEZ AS (DK) | 2001-12-05 | — | — | CN | claimed |
| WO-2025242789-A1 | METHOD FOR PRODUCING REINFORCED TEXTILE FIBER COMPOSITIONS | LIGAMORE APS (DK) | 2025-11-27 | — | — | WO | disclosed |
| EP-3444337-B1 | METHOD OF CLEANING | PROCTER & GAMBLE (US) | 2024-12-18 | — | — | EP | disclosed |
| EP-3444336-B1 | CLEANING AGENT | PROCTER & GAMBLE (US) | 2024-05-08 | — | — | EP | disclosed |
| CN-1206921-C | Antimicrobial composition comprising an oxidoreductase and an enhancing agent of the N-hydroxy anilide-type | NOVO JYMEZ AS (DK) | 2005-06-22 | — | — | CN | disclosed |
| US-6592867-B2 | Capable of killing or inhibiting microbial cells or micro-organisms in laundry, on hard surfaces, in water systems, on skin, on teeth or on mucous membranes | NOVOZYMES A/S (DK) | 2003-07-15 | — | — | US | disclosed |
| EP-1128730-B1 | ANTIMICROBIAL COMPOSITION COMPRISING AN OXIDOREDUCTASE AND AN ENHANCING AGENT OF THE N-HYDROXYANILIDE-TYPE | NOVOZYMES AS (DK) | 2003-05-02 | — | — | EP | disclosed |
| US-20020094331-A1 | ANTIMICROBIAL COMPOSITION CONTAINING AN OXIDOREDUCTASE AND AN ENHANCER OF THER N-HYDROXYANILIDE-TYPE | NOVOZYMES A/S (DK) | 2002-07-18 | — | — | US | disclosed |
| CN-1325270-A | Antimicrobial composition comprising an oxidoreductase and an enhancing agent of the N-hydroxy anilide-type | NOVO JYMEZ AS (DK) | 2001-12-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020094331-A1 | ANTIMICROBIAL COMPOSITION CONTAINING AN OXIDOREDUCTASE AND AN ENHANCER OF THER N-HYDROXYANILIDE-TYPE | LPO, MPO, LCT | NPC1 4238/4885JAK2 4560/4885RAB9A 4091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.